117 related articles for article (PubMed ID: 28593747)
61. Plasma metabolites as possible biomarkers for diagnosis of breast cancer.
Park J; Shin Y; Kim TH; Kim DH; Lee A
PLoS One; 2019; 14(12):e0225129. PubMed ID: 31794572
[TBL] [Abstract][Full Text] [Related]
62. Metabolomics Reveals Novel Serum Metabolic Signatures in Gastric Cancer by a Mass Spectrometry Platform.
Yu J; Zhao J; Yang T; Feng R; Liu L
J Proteome Res; 2023 Mar; 22(3):706-717. PubMed ID: 36722497
[TBL] [Abstract][Full Text] [Related]
63. Metabolomic Signature of Endometrial Cancer.
Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
[TBL] [Abstract][Full Text] [Related]
64. Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.
Utikal J; Schadendorf D; Ugurel S
Arch Dermatol Res; 2007 Mar; 298(10):469-77. PubMed ID: 17221215
[TBL] [Abstract][Full Text] [Related]
65. Metabolomics of lung cancer: Analytical platforms and their applications.
Noreldeen HAA; Liu X; Xu G
J Sep Sci; 2020 Jan; 43(1):120-133. PubMed ID: 31747121
[TBL] [Abstract][Full Text] [Related]
66. Metabolite Profiling of Preneoplastic and Neoplastic Lesions of Oral Cavity Tissue Samples Revealed a Biomarker Pattern.
Musharraf SG; Shahid N; Naqvi SMA; Saleem M; Siddiqui AJ; Ali A
Sci Rep; 2016 Dec; 6():38985. PubMed ID: 27958349
[TBL] [Abstract][Full Text] [Related]
67. [Preliminary results of metabolite in serum and urine of lung cancer patients detected by metabolomics].
Niu Y; Jiang Y; Xu C; Wang X; Liu Y; Zhao H; Han B; Jiang L
Zhongguo Fei Ai Za Zhi; 2012 Apr; 15(4):195-201. PubMed ID: 22510503
[TBL] [Abstract][Full Text] [Related]
68. Blood groups in patients with malignant melanoma of the skin.
Ikonopisov RL; Tsanov TI
Tumori; 1974; 60(5):361-3. PubMed ID: 4456709
[No Abstract] [Full Text] [Related]
69. Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.
Ghannoum MA; Mukherjee PK; Jurevic RJ; Retuerto M; Brown RE; Sikaroodi M; Webster-Cyriaque J; Gillevet PM
OMICS; 2013 Jan; 17(1):5-15. PubMed ID: 21751871
[TBL] [Abstract][Full Text] [Related]
70. Combined Metabolomics with Transcriptomics Reveals Important Serum Biomarkers Correlated with Lung Cancer Proliferation through a Calcium Signaling Pathway.
Zheng Y; He Z; Kong Y; Huang X; Zhu W; Liu Z; Gong L
J Proteome Res; 2021 Jul; 20(7):3444-3454. PubMed ID: 34056907
[TBL] [Abstract][Full Text] [Related]
71. Alterations in plasma concentrations of energy-balance-related metabolites in patients with lung, or head & neck, cancers: Effects of radiotherapy.
Rodríguez-Tomàs E; Arguís M; Arenas M; Fernández-Arroyo S; Murcia M; Sabater S; Torres L; Baiges-Gayà G; Hernández-Aguilera A; Camps J; Joven J
J Proteomics; 2020 Feb; 213():103605. PubMed ID: 31841666
[TBL] [Abstract][Full Text] [Related]
72. Letter to the Editor regarding proteomic strategies and biomarker identification in melanoma.
Phelps A; Murphy MJ
Clin Biochem; 2013 Sep; 46(13-14):1309. PubMed ID: 23810584
[No Abstract] [Full Text] [Related]
73. Identification of three indolic compounds in a pigmented-melanoma cell-culture supernatant by gas chromatography-mass spectrometry.
Pavel S; Muskiet FA; de Ley L; The TH; van der Slik W
J Cancer Res Clin Oncol; 1983; 105(3):275-9. PubMed ID: 6853590
[TBL] [Abstract][Full Text] [Related]
74. The source of increased serum coeruloplasmin activity in rabbits bearing the VX-2 carcinoma.
Ugar-Waron H; Gluckman A; Trainin Z
J Comp Pathol; 1982 Apr; 92(2):331-6. PubMed ID: 7085949
[No Abstract] [Full Text] [Related]
75. A diagnostic autoantibody signature for primary cutaneous melanoma.
Zaenker P; Lo J; Pearce R; Cantwell P; Cowell L; Lee M; Quirk C; Law H; Gray E; Ziman M
Oncotarget; 2018 Jul; 9(55):30539-30551. PubMed ID: 30093967
[TBL] [Abstract][Full Text] [Related]
76. A case report - Volatile metabolomic signature of malignant melanoma using matching skin as a control.
Abaffy T; Möller M; Riemer DD; Milikowski C; Defazio RA
J Cancer Sci Ther; 2011; 3(6):140-144. PubMed ID: 22229073
[TBL] [Abstract][Full Text] [Related]
77. Non-invasive skin sampling detects systemically administered drugs in humans.
Panitchpakdi M; Weldon KC; Jarmusch AK; Gentry EC; Choi A; Sepulveda Y; Aguirre S; Sun K; Momper JD; Dorrestein PC; Tsunoda SM
PLoS One; 2022; 17(7):e0271794. PubMed ID: 35881585
[TBL] [Abstract][Full Text] [Related]
78. Is C-Reactive Protein a Specific Marker in Melanoma?
Li Z; Feng J; Sun X
J Clin Oncol; 2015 Nov; 33(31):3673-4. PubMed ID: 26240228
[No Abstract] [Full Text] [Related]
79. Reply to Z. Li et al.
Fang S; Wang Y; Amos CI; Lee JE
J Clin Oncol; 2015 Nov; 33(31):3674-5. PubMed ID: 26240223
[No Abstract] [Full Text] [Related]
80. Biomarkers--select biosciences' third European summit.
Shah S
IDrugs; 2008 Dec; 11(12):876-9. PubMed ID: 19051147
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
